Molecule Holdings Stock Today
| EVRRF Stock | USD 0 0.00 0.00% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Molecule Holdings is trading at 0.0025 as of the 19th of March 2025. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0025. Molecule Holdings has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Molecule Holdings Inc. engages in production and co-packing of cannabis-infused beverages in Canada. It offers its beverage products under the PHRESH, embody, and CANAJO brands. Molecule Holdings is traded on OTC Exchange in the United States. The company has 97.78 M outstanding shares. More on Molecule Holdings
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Molecule Pink Sheet Highlights
| Business Concentration | Materials, Metals & Mining, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Molecule Holdings [EVRRF] is a Pink Sheet which is traded through a dealer network over-the-counter (OTC). The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Molecule Holdings's market, we take the total number of its shares issued and multiply it by Molecule Holdings's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Molecule Holdings classifies itself under Metals & Mining sector and is part of Materials industry. The entity has 97.78 M outstanding shares.
Molecule Holdings has accumulated about 73.25 K in cash with (2.87 M) of positive cash flow from operations.
Check Molecule Holdings Probability Of Bankruptcy
Ownership AllocationMolecule Holdings maintains a total of 97.78 Million outstanding shares. Molecule Holdings secures 16.52 % of its outstanding shares held by insiders and 0.0 % owned by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Molecule Ownership Details
Molecule Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Molecule Holdings without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Molecule Holdings Corporate Management
| Jeffrey Stoss | Chief Officer | Profile | |
| Becky Griffin | Chief Officer | Profile | |
| Tiago Zamponi | Head Sales | Profile | |
| David Reingold | Pres CEO | Profile | |
| Andre BComm | CoFounder Chairman | Profile | |
| Amy Proulx | CoFounder Director | Profile | |
| Philip Waddington | COO Director | Profile |
Other Information on Investing in Molecule Pink Sheet
Molecule Holdings financial ratios help investors to determine whether Molecule Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Molecule with respect to the benefits of owning Molecule Holdings security.